June 1, 2023 | BALTIMORE – Complete Omics’ Clinical Metablomics team are overjoyed to announce that Dr. Liang Zhao, an esteemed expert in metabolomics, proteomics, and lipidomics, with a profound focus on cancer metabolism and immuno-metabolism, has joined our MyMeta Force team as the leader. Dr. Zhao’s pioneering research involves the sophisticated application of mass spectrometry-based metabolomics and proteomics, alongside integrating molecular biology and bioinformatics, to unravel the biomedical significance of metabolites and proteins. His dedication to translating omics findings into clinical applications is notable, aiming at the development of innovative biomarkers, AI-enhanced diagnostic panels, and novel therapeutic strategies for cancer treatment.
Dr. Zhao’s specialties encompass tumor metabolism, immuno-metabolism, stable isotope labeling, metabolic flux analysis, and the cutting-edge utilization of mass spectrometry and bioinformatics. His impressive body of work, which includes over 2,800 citations, underscores his significant contributions to our understanding of metabolic processes in cancer and the immune response.
We are excited for Dr. Zhao to bring his wealth of knowledge and innovative approach to our team. His leadership is expected to propel MyMeta Force into new realms of discovery and success in metabolomics research and its applications in cancer therapy and diagnostics.
Join us in extending a warm welcome to Dr. Liang Zhao, a visionary in the field, as he leads us toward groundbreaking advancements.
Welcome aboard, Dr. Zhao!
